Ribosome Profiling Reveals a Cell-Type-Specific Translational Landscape in Brain Tumors

Glioma growth is driven by signaling that ultimately regulates protein synthesis. Gliomas are also complex at the cellular level and involve multiple cell types, including transformed and reactive cells in the brain tumor microenvironment. The distinct functions of the various cell types likely lead to different requirements and regulatory paradigms for protein synthesis. Proneural gliomas can arise from transformation of glial progenitors that are driven to proliferate via mitogenic signaling that affects translation. To investigate translational regulation in this system, we developed a RiboTag glioma mouse model that enables cell-type-specific, genome-wide ribosome profiling of tumor tissue. Infecting glial progenitors with Cre-recombinant retrovirus simultaneously activates expression of tagged ribosomes and delivers a tumor-initiating mutation. Remarkably, we find that although genes specific to transformed cells are highly translated, their translation efficiencies are low compared with normal brain. Ribosome positioning reveals sequence-dependent regulation of ribosomal activity in 5′-leaders upstream of annotated start codons, leading to differential translation in glioma compared with normal brain. Additionally, although transformed cells express a proneural signature, untransformed tumor-associated cells, including reactive astrocytes and microglia, express a mesenchymal signature. Finally, we observe the same phenomena in human disease by combining ribosome profiling of human proneural tumor and non-neoplastic brain tissue with computational deconvolution to assess cell-type-specific translational regulation.

[1]  N. Socci,et al.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.

[2]  E. Holland,et al.  Cooperative translational control of gene expression by Ras and Akt in cancer. , 2004, Trends in molecular medicine.

[3]  G. Mills,et al.  Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. , 2005, Cancer research.

[4]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[5]  M. Assanah,et al.  Glial Progenitors in Adult White Matter Are Driven to Form Malignant Gliomas by Platelet-Derived Growth Factor-Expressing Retroviruses , 2006, The Journal of Neuroscience.

[6]  M. Berens,et al.  Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.

[7]  L. Vallières,et al.  Identification of genes preferentially expressed by microglia and upregulated during cuprizone‐induced inflammation , 2007, Glia.

[8]  K. Shokat,et al.  A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. , 2007, Cancer research.

[9]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[10]  P. Greengard,et al.  Resource Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types , 2009 .

[11]  P. Greengard,et al.  A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types , 2008, Cell.

[12]  P. Greengard,et al.  Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types , 2008, Cell.

[13]  Nicholas T. Ingolia,et al.  Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling , 2009, Science.

[14]  B. Jiang,et al.  PI3K/PTEN signaling in angiogenesis and tumorigenesis. , 2009, Advances in cancer research.

[15]  R. Palmiter,et al.  Cell-type-specific isolation of ribosome-associated mRNA from complex tissues , 2009, Proceedings of the National Academy of Sciences.

[16]  Frederick P. Roth,et al.  Next generation software for functional trend analysis , 2009, Bioinform..

[17]  O. Elemento,et al.  Revealing global regulatory perturbations across human cancers. , 2009, Molecular cell.

[18]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[19]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[20]  Nicholas T. Ingolia,et al.  Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes , 2011, Cell.

[21]  D. Gutmann,et al.  The ecology of brain tumors: lessons learned from neurofibromatosis-1 , 2011, Oncogene.

[22]  W. Cavenee,et al.  Heterogeneity maintenance in glioblastoma: a social network. , 2011, Cancer research.

[23]  R. Faull,et al.  Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain , 2011, Nature Methods.

[24]  L. Luo,et al.  Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma , 2011, Cell.

[25]  T. Ludwig,et al.  Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype , 2011, PloS one.

[26]  Nicholas T. Ingolia,et al.  High-Resolution View of the Yeast Meiotic Program Revealed by Ribosome Profiling , 2011, Science.

[27]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[28]  M. Setty,et al.  Identification of Global Alteration of Translational Regulation in Glioma In Vivo , 2012, PloS one.

[29]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[30]  E. Holland,et al.  Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment , 2012, PloS one.

[31]  Nicholas T. Ingolia,et al.  The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.

[32]  Anna M. McGeachy,et al.  The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments , 2012, Nature Protocols.

[33]  P. Canoll,et al.  Murine cell line model of proneural glioma for evaluation of anti-tumor therapies , 2013, Journal of Neuro-Oncology.

[34]  Anne E Willis,et al.  A perspective on mammalian upstream open reading frame function , 2013, The International Journal of Biochemistry & Cell Biology.

[35]  Joshua A. Arribere,et al.  Roles for transcript leaders in translation and mRNA decay revealed by transcript leader sequencing , 2013, Genome research.

[36]  L. Romão,et al.  Gene Expression Regulation by Upstream Open Reading Frames and Human Disease , 2013, PLoS genetics.

[37]  Andrea Califano,et al.  The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression. , 2014, Cancer research.

[38]  Jeffrey A. Magee,et al.  Haematopoietic stem cells require a highly regulated protein synthesis rate , 2014, Nature.

[39]  Christos G. Gkogkas,et al.  Multifaceted regulation of somatic cell reprogramming by mRNA translational control. , 2014, Cell stem cell.